Cell name:
MOLT-4
Other names for the model:
Molt-4、MOLT 4、Molt 4、MOLT.4、MOLT4、Molt4、GM02219、GM02219C、GM2219C 、GM02219D、Accession CVCL_0013
Cell information:
MOLT-4 cells are derived from human acute lymphoblastic leukemia cells. The MOLT-4 cell line is of T lymphocyte origin. There is a G→A mutation in codon 248 of the p53 gene. It does not express p53, immunoglobulin or Epstein-Barr virus; it can produce high levels of terminal deoxyribose transferase; Expresses CD1 (49%), CD2 (35%), CD3 A (26%) B (33%) C (34%), CD4 (55%), CD5 (72%), CD6 (22%), CD7 ( 77%). Click to viewMore information.
Model information:
Subcutaneous inoculation, the mouse strain is NOD/SCID, and matrix needs to be added during inoculation. Approximately 21 days after vaccination, the group can be divided into groups, and the administration time after grouping is approximately 19 days.Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059